Related Experiment Videos
Anemia in kidney transplanted patients
Miklos Zs Molnar1, Marta Novak, Csaba Ambrus
1Institute of Behavioral Sciences, Semmelweis University, Budapest, Hungary.
Clinical Transplantation
|November 30, 2005
Summary
Anemia affects one-third of renal transplant recipients and is linked to malnutrition and inflammation. Early detection and treatment are crucial for better patient outcomes.
Area of Science:
- Nephrology
- Transplantation
- Hematology
Background:
- Anemia is a recognized cardiovascular risk factor in renal transplant recipients.
- This condition is gaining increasing attention in recent years.
- Cardiovascular disease is a leading cause of mortality in this patient group.
Purpose of the Study:
- To determine the prevalence of anemia in renal transplant recipients.
- To identify factors associated with post-transplant anemia.
- To assess the current treatment patterns for anemia in this population.
Main Methods:
- A cross-sectional study was conducted with 959 renal transplant recipients.
- Anemia was defined using American Society of Transplantation guidelines (Hb < or =130 g/L in males, < or =120 g/L in females).
- Statistical analyses, including multivariate analysis, were used to identify associated factors.
Main Results:
- 34% of patients had anemia, with similar prevalence in males and females.
- Anemia was significantly correlated with estimated glomerular filtration rate (eGFR), serum transferrin, and serum albumin.
- Malnutrition and/or chronic inflammation markers (eGFR, albumin, transferrin) and iron deficiency were independently associated with anemia.
Conclusions:
- Post-transplant anemia is prevalent and often under-treated.
- Protein/energy malnutrition and chronic inflammation may be independently associated with anemia.
- Further research is needed to evaluate the impact of anemia treatment on long-term outcomes.